Arilac Soothing Mask Sheet Pack
Chamaecyparis Obtusa Water, Aloe Barbadensis Leaf Extract
Menapay Inc.
Human Otc Drug
NDC 81758-030Arilac Soothing Mask Sheet Pack also known as Chamaecyparis Obtusa Water, Aloe Barbadensis Leaf Extract is a human otc drug labeled by 'Menapay Inc.'. National Drug Code (NDC) number for Arilac Soothing Mask Sheet Pack is 81758-030. This drug is available in dosage form of Patch. The names of the active, medicinal ingredients in Arilac Soothing Mask Sheet Pack drug includes Aloe Vera Leaf - 6.295 g/100mL Chamaecyparis Obtusa Wood Oil - 30 g/100mL . The currest status of Arilac Soothing Mask Sheet Pack drug is Active.
Drug Information:
| Drug NDC: | 81758-030 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Arilac Soothing Mask Sheet Pack |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Chamaecyparis Obtusa Water, Aloe Barbadensis Leaf Extract |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Menapay Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Patch |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ALOE VERA LEAF - 6.295 g/100mL
CHAMAECYPARIS OBTUSA WOOD OIL - 30 g/100mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 May, 2021 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 10 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Menapay Inc.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | ZY81Z83H0X
P2OMP71Y62
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 81758-030-02 | 5 POUCH in 1 CARTON (81758-030-02) / 25 mL in 1 POUCH (81758-030-01) | 01 May, 2021 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose soothing
Product Elements:
Arilac soothing mask sheet pack chamaecyparis obtusa water, aloe barbadensis leaf extract chamaecyparis obtusa wood oil chamaecyparis obtusa wood oil aloe vera leaf aloe vera leaf water butylene glycol
Indications and Usage:
Uses helps to soothe facial skin
Warnings:
Warnings for external use only 1. if there is any red spot, swallowing or itching by direct sunlight or if there is any other adverse effect during or after cosmetics use, consult with a doctor. 2. refrain from using on the injured area 3. precaution for storage and handling a) keep out of reach of children b) keep away from direct sunlight 4. keep the essence away from getting into your eyes.
Dosage and Administration:
Directions 1. gently prepare your face with toner after cleansing. 2. put the sheet mask on evenly over your face. 3. detach the sheet mask after 10 to 15min and gently pat the remaining emulsion essence for absorption.
Package Label Principal Display Panel:
Package label.principal display panel image of carton